NCT01155362Phase 2Completed

PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

Study sponsor: Celularity Incorporated

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2012-02Actual
Enrollment · participants50Actual
Source updated2026-07-07Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: A reduction from baseline by 25% and/or > 100 points in the Crohn's Disease Activity Index (CDAI) scores at both Week 4 (Day 29) and at Week 6 (Day 43).. After: Measure: Percentage of Subjects With Clinical Response Based on Crohn's Disease Activity Index (CDAI) at Both Week 4 and Week 6.

Check registry source